Henrik Möbitz
Impact in
-
- Computational Drug Discovery Methods
-
- Epigenetics and DNA Methylation
- Cancer-related gene regulation
- Melanoma and MAPK Pathways
- Protein Structure and Dynamics
- Protein Degradation and Inhibitors
Papers in
-
- Melanoma and MAPK Pathways 5
- Cancer-related gene regulation 5
- Epigenetics and DNA Methylation 3
- Microbial Metabolic Engineering and Bioproduction 3
- Protein Structure and Dynamics 3
-
- Computational Drug Discovery Methods 6
- Co-authors
- Sandra W. Cowan‐Jacob (4 shared papers)Doriano Fabbro (2 shared papers)Matthias Boll (2 shared papers)Georg Martiny‐Baron (2 shared papers)Rainer Machauer (4 shared papers)Clemens Scheufler (6 shared papers)Sandrine Desrayaud (3 shared papers)Heinrich Rueeger (3 shared papers)
- Journals
- ACS Medicinal Chemistry Letters (4 papers)Bioorganic & Medicinal Chemistry Letters (4 papers)Journal of Medicinal Chemistry (4 papers)Biochemistry (3 papers)ChemMedChem (2 papers)
- Partner nations
- SwitzerlandGermanyUnited States
In The Last Decade
Henrik Möbitz
25 papers receiving 808 citations
Peers
Comparison fields: 5 of 85
- Computational Theory and Mathematics 162
- Molecular Biology 551
- Hematology 67
- Organic Chemistry 167
- Oncology 134
Countries citing papers authored by Henrik Möbitz
This map shows the geographic impact of Henrik Möbitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Henrik Möbitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Henrik Möbitz more than expected).
Fields of papers citing papers by Henrik Möbitz
This network shows the impact of papers produced by Henrik Möbitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Henrik Möbitz. The network helps show where Henrik Möbitz may publish in the future.
Co-authors
The 25 scholars most cited alongside Henrik Möbitz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 95 | |
| 2 | 2015 | 83 | |
| 3 | 2012 | 82 | |
| 4 | 2015 | 68 | |
| 5 | 2016 | 51 | |
| 6 | 2002 | 50 | |
| 7 | 2000 | 44 | |
| 8 | 2017 | 42 | |
| 9 | 2009 | 41 | |
| 10 | 2016 | 37 | |
| 11 | 2011 | 32 | |
| 12 | 2019 | 27 | |
| 13 | 2010 | 27 | |
| 14 | 2010 | 23 | |
| 15 | 2013 | 22 | |
| 16 | 2004 | 18 | |
| 17 | 2016 | 17 | |
| 18 | 2015 | 14 | |
| 19 | 2004 | 14 | |
| 20 | 2016 | 13 |
About Henrik Möbitz
Henrik Möbitz is a scholar working on Molecular Biology, Computational Theory and Mathematics, Oncology, Organic Chemistry and Hematology, having authored 26 papers that have together received 833 indexed citations. Recurring topics across this work include Computational Drug Discovery Methods (6 papers), Melanoma and MAPK Pathways (5 papers), Cancer-related gene regulation (5 papers), Synthesis and biological activity (3 papers), Epigenetics and DNA Methylation (3 papers), Microbial Metabolic Engineering and Bioproduction (3 papers), Protein Structure and Dynamics (3 papers) and Enzyme Structure and Function (3 papers). The work is most often cited by research in Computational Theory and Mathematics (162 citations), Molecular Biology (551 citations), Hematology (67 citations), Organic Chemistry (167 citations) and Oncology (134 citations). Henrik Möbitz has collaborated with scholars based in Switzerland, Germany and United States. Frequent co-authors include Sandra W. Cowan‐Jacob, Doriano Fabbro, Matthias Boll, Georg Martiny‐Baron, Rainer Machauer, Clemens Scheufler, Sandrine Desrayaud, Heinrich Rueeger, Ulf Neumann and Jean‐Michel Rondeau. Their work appears in journals such as ACS Medicinal Chemistry Letters, Bioorganic & Medicinal Chemistry Letters, Journal of Medicinal Chemistry, Biochemistry and ChemMedChem.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.